Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
